Recent Advances in the Treatment of Mantle Cell Lymphoma

Introduction

Take This Event

Mantle cell lymphoma (MCL) is a distinct type of non-Hodgkin lymphoma that typically affects older adults. It presents with symptoms like lymphadenopathy and splenomegaly. Standard treatments include chemoimmunotherapy and targeted therapies, which vary in effectiveness and side effects. Despite advances, MCL remains challenging to treat, necessitating ongoing research. This presentation will cover MCL's key features, treatment options, and emerging therapies.

Objectives

1. Clarify the key characteristics, clinical presentations, and diagnostic criteria of mantle cell lymphoma.
2. Describe the standard treatment protocols, therapeutic options, and their effectiveness and side effects.
3. Explain the emerging therapies and clinical trials in the treatment landscape of mantle cell lymphoma.

Speaker

Dr Ibrahim Motebi

Director, Adult Hematology Fellowship Program King Fahad Medical City

Riyadh, Kingdom of Saudi Arabia

Dr Ayman Ibrahim

Consultant Haematologist, King Abdulaziz Medical City- National Guard Health Affairs - Riyadh

Dr.Mohammed Aldarweesh

Consultant Adult hematology, Lymphoma, Myeloma and Stem cell transplant at KFSHD